Short Interest in CSL Limited (OTCMKTS:CSLLY) Expands By 4,100.0%

CSL Limited (OTCMKTS:CSLLY - Get Free Report) saw a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 12,600 shares, an increase of 4,100.0% from the March 15th total of 300 shares. Based on an average daily volume of 201,200 shares, the short-interest ratio is presently 0.1 days. Currently, 0.0% of the shares of the stock are sold short.

CSL Price Performance

OTCMKTS CSLLY traded down $0.32 during trading hours on Friday, hitting $76.74. The company had a trading volume of 59,864 shares, compared to its average volume of 97,754. CSL has a 1-year low of $70.22 and a 1-year high of $109.00. The business has a 50 day moving average of $79.58 and a 200-day moving average of $87.22. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.97 and a current ratio of 2.18.

Wall Street Analyst Weigh In

Separately, The Goldman Sachs Group raised CSL to a "strong-buy" rating in a report on Thursday, January 16th.

CSL Company Profile

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.